摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 1314884-52-0

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
1314884-52-0
化学式
C15H17N3O2S2
mdl
——
分子量
335.451
InChiKey
KMNGRPRICNLESG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.91
  • 重原子数:
    22.0
  • 可旋转键数:
    5.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    79.35
  • 氢给体数:
    2.0
  • 氢受体数:
    6.0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2,5-二羟基苯甲醛盐酸 作用下, 以 甲醇 为溶剂, 反应 0.5h, 以19%的产率得到2-(2,5-Dihydroxyphenyl)-6-[(3-morpholin-4-ylphenyl)methylsulfanyl]-4-oxo-2,3-dihydro-1,3-thiazine-5-carbonitrile
    参考文献:
    名称:
    Structure–Activity Analysis and Cell-Based Optimization of Human Galactokinase Inhibitors
    摘要:
    Classic galactosemia is a rare human disease associated with the accumulation of a toxic level of galactose-1-phosphate (gal-1P) caused by the inherited deficiency of galactose-1-phosphate uridyltransferase (GALT) activity. To reduce the toxic level of gal-1P in patients, we have identified, via high-throughput screening, over 200 small molecule GALK inhibitors. We selected a 4-oxo-3,4-dihydro-2H-1,3-thiazine-5-carbonitrile scaffold for further structure-activity relationships characterization, lead optimization with regards to potency, and efficacy to reduce gal-1P accumulation in patient cells.
    DOI:
    10.1021/ml200131j
  • 作为产物:
    描述:
    3-(4-吗啉基)苯甲醇N-溴代丁二酰亚胺(NBS)二甲基硫 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 6.0h, 生成
    参考文献:
    名称:
    Structure–Activity Analysis and Cell-Based Optimization of Human Galactokinase Inhibitors
    摘要:
    Classic galactosemia is a rare human disease associated with the accumulation of a toxic level of galactose-1-phosphate (gal-1P) caused by the inherited deficiency of galactose-1-phosphate uridyltransferase (GALT) activity. To reduce the toxic level of gal-1P in patients, we have identified, via high-throughput screening, over 200 small molecule GALK inhibitors. We selected a 4-oxo-3,4-dihydro-2H-1,3-thiazine-5-carbonitrile scaffold for further structure-activity relationships characterization, lead optimization with regards to potency, and efficacy to reduce gal-1P accumulation in patient cells.
    DOI:
    10.1021/ml200131j
点击查看最新优质反应信息